Abstract:Human adaptive immunity is orchestrated by effector and regulatory T (Treg) cells. Natural Tregs arise in the thymus where they are shaped to recognize self-antigens, while type 1 Tregs or Tr1 cells are induced from conventional peripheral CD4 T cells in response to peripheral antigens, such as alloantigens and allergens. Tr1 cells have been developed as a potential therapy for inducing antigen-specific tolerance, because they can be rapidly differentiated in response to a target antigen. However, the epigenetic landscape and the identity of transcription factors (TFs) that regulate differentiation, phenotype, and functions of human antigen-specific Tr1 cells is largely unknown, hindering Tr1 research and broader clinical development. Here, we reveal the unique epigenetic signature of antigen-specific Tr1 cells, and TFs that regulate their differentiation, phenotype and function. We showed that induced antigen-specific Tr1 cells are distinct both clonally and transcriptionally from natural Tregs and other conventional CD4 T cells on a single-cell level. An integrative analysis of Tr1 cell epigenome and transcriptome identified a TF signature unique to antigen-specific Tr1 cells, and predicted that IRF4, BATF, and MAF act as their transcriptional regulators. Using functional genomics, we showed that each of these TFs play a non-redundant role in regulating Tr1 cell differentiation, suppressive function, and expression of co-inhibitory and cytotoxic proteins. By using the Tr1-specific TF signature as a molecular fingerprint, we tracked Tr1 cells in peripheral blood of recipients of allogeneic hematopoietic stem cell transplantation treated with adoptive Tr1 cell therapy. Furthermore, the same signature identified Tr1 cells in resident CD4 T cells in solid tumors. Altogether, these results reveal the epigenetic signature and the key transcriptional regulators of human Tr1 cells. These data will guide mechanistic studies of human Tr1 cell biology and the development and optimization of adoptive Tr1 cell therapies.

Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells

Lineage Tracking the Generation of T Regulatory Cells From Microbial Activated T Effector Cells in Naive Mice

CD8+ Resident Memory T Cells and Viral Infection

Generation and Regulation of CD8(+) Regulatory T Cells.

CD8+ Tissue-Resident Memory T Cells: Versatile Guardians of the Tissue

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells

Effector TH17 Cells Give Rise to Long-Lived TRM Cells that Are Essential for an Immediate Response against Bacterial Infection

The role of circulating T cells with a tissue resident phenotype (ex-TRM) in health and disease

Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.

Tissue-resident memory T cells: local specialists in immune defence

Excess generation and activation of naturally arising memory-phenotype CD4+ T lymphocytes are inhibited by regulatory T cells in steady state

Tissue-Resident Memory T Cell: Ontogenetic Cellular Mechanism and Clinical Translation

Tissue-resident memory T cells: Harnessing their properties against infection for cancer treatment

Tissue-resident memory T cells in breast cancer control and immunotherapy responses

Resident memory CD8 T cells trigger protective innate and adaptive immune responses

The emerging role of effector functions exerted by tissue-resident memory T cells

Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells

Quiescence of Memory CD8(+) T Cells Is Mediated by Regulatory T Cells through Inhibitory Receptor CTLA-4

Divergent molecular networks program functionally distinct CD8 + skin-resident memory T cells

CD4+ T cell memory is impaired by species-specific cytotoxic differentiation, but not by TCF-1 loss

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions